who invented glp-1 drugs Biochemist discovered named winner of 2026 Kimberly Prize: For Journalists Looming GLP-1 drug patent expirations

Data curation, YG, and JG

Yakubova .2026

Eli Lilly used its voucher for orforglipron, approved on April 1, 2026, under the brand name Foundayo, and described by the agency as the fastest approval of a new molecular entity since 2002

Higher doses can stall the same process or even tip into toxicity over longer exposures, where free copper drifting loose from the complex starts driving oxidative damage

Abstract Reactive oxygen species (ROS), inevitable byproducts of aerobic respiration, exhibit both signaling and cytotoxic effects depending on concentration within cells

Another potential risk is the possibility of an allergic reaction to the ingredients used in the injection